Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lina Inagaki
Observed names:
L Inagaki,
L. Inagaki,
LINA INAGAKI
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Emory University,
Tokyo Metropolitan Komagome Hospital,
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research,
National Cancer Center Hospital
ORCID:
0009-0001-9290-6816
Observed ORCID:
0009-0001-9290-6816
OpenAlex ID:
A5032840659
Lenvatinib for Anaplastic Thyroid Cancer
2017
·
Makoto Tahara
, Naomi Kiyota
, et al.
·
Frontiers in Oncology
·
205
PDF
A Phase II Study of the Safety and Efficacy of Lenvatinib in Patients with Advanced Thyroid Cancer
2019
·
Shunji Takahashi
, Naomi Kiyota
, et al.
·
Future Oncology
·
150
PDF
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
2022
·
Yoon Ming Chin
, Tomoko Shibayama
, et al.
·
Cancer Science
·
38
PDF
Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.
2016
·
Shunji Takahashi
, Naomi Kiyota
, et al.
·
Journal of Clinical Oncology
·
27
Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy
2015
·
KENJI NAKANO
, YASUYOSHI SATO
, et al.
·
Molecular and Clinical Oncology
·
18
PDF
Incidence of Pneumothorax in Advanced and/or Metastatic Soft Tissue Sarcoma Patients during Pazopanib Treatment
2014
·
K. Nakano
, L. Inagaki
, et al.
·
Clinical Oncology
·
16
Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study
2015
·
K. Nakano
, N. Motoi
, et al.
·
Japanese Journal of Clinical Oncology
·
14
Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation
2010
·
M Tsubokura
, T Yamashita
, et al.
·
Bone Marrow Transplantation
·
13
The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
2022
·
Yukinori Ozaki
, Jun Masuda
, et al.
·
Cancer Reports
·
11
Assessment of a cancer genomic profile test for patients with metastatic breast cancer
2022
·
Ippei Fukada
, Seiichi Mori
, et al.
·
Scientific Reports
·
11
PDF
Myocardial dysfunction caused by abemaciclib: a case report
2021
·
Takuya Oyakawa
, Lina Inagaki
, et al.
·
International Cancer Conference Journal
·
11
Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia
2023
·
Hitomi Sumiyoshi Okuma
, Hiroshi Yoshida
, et al.
·
Cancer Science
·
9
PDF
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
2022
·
Yukinori Ozaki
, Yosuke Aoyama
, et al.
·
BMC Cancer
·
9
PDF
Risk factors and long-term prognostic impact of trastuzumab deruxtecan-related interstitial lung disease in metastatic breast cancer.
2026
·
Takayuki Kobayashi
, Meiko Nishimura
, et al.
·
Journal of Clinical Oncology
·
1
Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center
2020
·
Yukinori Ozaki
, Jun Masuda
, et al.
·
Cancer Cell
·
1
PDF
Risk Factors of Prolonged Duration of Gastrosoma Placement in Locally Advanced Head and Neck Cancer Patients with Ccrt
2014
·
Yasuyoshi Sato
, Kenji Nakano
, et al.
·
Annals of Oncology
·
1
Survival after second primary lung cancer following non-Hodgkin lymphoma: A U.S. population-based study.
2014
·
LINA INAGAKI
, Kevin C. Ward
·
Journal of Clinical Oncology
·
1
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE)
2026
·
Yukinori Ozaki
, Emi Taniguchi
, et al.
·
The Breast
S-1 versus capecitabine as first-line chemotherapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer in the era of cyclin-dependent kinase 4/6 inhibitors: a retrospective cohort study
2026
·
Takayuki Kobayashi
, Meiko Nishimura
, et al.
·
BMC Cancer
Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer
2026
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
BMC Cancer
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor–positive, HER2-negative metastatic breast cancer
2026
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
Breast Cancer
PDF
Efficacy of datopotamab deruxtecan after trastuzumab deruxtecan in metastatic hormone receptor–positive HER2-negative breast cancer: A real-world study.
2026
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
Journal of Clinical Oncology
PDF
Abstract P4-11-06: Effect of suppressed ovarian function on prognosis of premenopausal obese women with hormone receptor-positive breast cancer: A single-institute retrospective study
2022
·
Yukinori Ozaki
, Jun Masuda
, et al.
·
Cancer Research
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
2022
·
Takayo Fukuda
, Masaya Hattori
, et al.
·
Cancer Research
MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer
2021
·
Lina Inagaki
, Takayo Fukuda
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
28
Citation count:
536
H-index:
11
I10-index:
11
Year
Topic
Type